Fear of cancer recurrence in lymphoma survivors: A descriptive study

References

• Humphris G, Rogers S, McNally D, Lee-Jones C, Brown J, Vaughan D. Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg. 2003;32(5):486–491.
   PubMed Web of Science ®Google Scholar
• Jimenez RB, Perez GK, Rabin J, et al. Fear of recurrence among cancer survivors. J Clin Oncol. 2017;35(15_suppl):10053–10053. doi:10.1200/JCO.2017.35.15_suppl.10053
   Google Scholar
• Simard S, Savard J. Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241. doi:10.1007/s00520-008-0444-y
   PubMed Web of Science ®Google Scholar
• Vickberg S. Fears about breast cancer recurrence. Cancer Pract. 2001;9(5):237–243.
   PubMedGoogle Scholar
• Vickberg S. The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25(1):16–24. doi:10.1207/S15324796ABM2501_03
   PubMed Web of Science ®Google Scholar
• Lebel S, Maheu C, Lefebvre M, et al. Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv. 2014;8(3):485–496. doi:10.1007/s11764-014-0357-3
   PubMed Web of Science ®Google Scholar
• Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–322. doi:10.1007/s11764-013-0272-z
   PubMed Web of Science ®Google Scholar
• van de Wal M, van de Poll‐Franse L, Prins J, Gielissen M. Does fear of cancer recurrence differ between cancer types? A study from the population‐based PROFILES registry. Psycho‐Oncology 2016;25(7):772–778. doi:10.1002/pon.4002
   PubMed Web of Science ®Google Scholar
• Thompson C, Charlson M, Schenkein E, et al. Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann Oncol. 2010;21(11):2262–2266. doi:10.1093/annonc/mdq215
   PubMed Web of Science ®Google Scholar
• Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self‐report measures. Psycho‐Oncology 2012;21(6):571–587. doi:10.1002/pon.2070
   PubMed Web of Science ®Google Scholar
• Lebel S, Ozakinci G, Humphris G, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24(8):3265–3268. doi:10.1007/s00520-016-3272-5
   PubMed Web of Science ®Google Scholar
• Champagne A, Ivers H, Savard J. Utilization of health care services in cancer patients with elevated fear of cancer recurrence. Psycho‐Oncology 2018;27(8):1958–1964.
   PubMed Web of Science ®Google Scholar
• Hall DL, Luberto CM, Philpotts LL, Song R, Park ER, Yeh GY. Mind‐body interventions for fear of cancer recurrence: a systematic review and meta‐analysis. Psycho‐Oncology 2018;27(11):2546–2558.
   PubMed Web of Science ®Google Scholar
• Leske S, Smith AB, Lambert SD, Girgis A. A protocol for an updated and expanded systematic mixed studies review of fear of cancer recurrence in families and caregivers of adults diagnosed with cancer. Syst Rev. 2018;7(1):134. doi:10.1186/s13643-018-0795-5
   PubMedGoogle Scholar
• Koch-Gallenkamp L, Bertram H, Eberle A, et al. Fear of recurrence in long-term cancer survivors—do cancer type, sex, time since diagnosis, and social support matter? Health Psychology. 2016;35(12):1329. doi:10.1037/hea0000374
   PubMed Web of Science ®Google Scholar
• Butow P, Sharpe L, Thewes B, Turner J, Gilchrist J, Beith J. Fear of cancer recurrence: a practical guide for clinicians. Oncology (Williston Park, N.Y.) 2018;32(1):32–38.
   PubMed Web of Science ®Google Scholar
• Kochenderfer JN, Somerville RP, Lu T, et al. Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels. J Clin Oncol. 2017;35(16):1803–1813. doi:10.1200/JCO.2016.71.3024
   PubMed Web of Science ®Google Scholar
• Maurer MJ, Ghesquières H, Jais J-P, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol. 2014;32(10):1066. doi:10.1200/JCO.2013.51.5866
   PubMed Web of Science ®Google Scholar
• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. Cancer J Clin. 2016;66(4):271–289. doi:10.3322/caac.21349
   PubMed Web of Science ®Google Scholar
• Oerlemans S, Mols F, Nijziel MR, Zijlstra WP, Coebergh JWW, van de Poll-Franse LV. The course of anxiety and depression for patients with Hodgkin’s lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry. J Cancer Surviv. 2014;8(4):555–564. doi:10.1007/s11764-014-0367-1
   PubMed Web of Science ®Google Scholar
• Connors JM. State-of-the-art therapeutics: Hodgkin's lymphoma. J Clin Oncol. 2005;23(26):6400–6408. doi:10.1200/JCO.2005.05.016
   PubMed Web of Science ®Google Scholar
• Leventhal H, Leventhal EA, Contrada RJ. Self-regulation, health, and behavior: A perceptual-cognitive approach. Psychol Health. 1998;13(4):717–733. doi:10.1080/08870449808407425
   Web of Science ®Google Scholar
• Meyer D, Leventhal H, Gutmann M. Common-sense models of illness: the example of hypertension. Health Psychol. 1985;4(2):115. doi:10.1037/0278-6133.4.2.115
   PubMed Web of Science ®Google Scholar
• Simonelli LE, Siegel SD, Duffy NM. Fear of cancer recurrence: a theoretical review and its relevance for clinical presentation and management. Psycho‐oncology 2017;26(10):1444–1454. doi:10.1002/pon.4168
   PubMed Web of Science ®Google Scholar
• Fardell JE, Thewes B, Turner J, et al. Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation. J Cancer Surviv. 2016;10(4):663–673. doi:10.1007/s11764-015-0512-5
   PubMed Web of Science ®Google Scholar
• Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res. 1992;16(2):143–163. doi:10.1007/BF01173486
   Web of Science ®Google Scholar
• Cameron L, Leventhal EA, Leventhal H. Symptom representations and affect as determinants of care seeking in a community-dwelling, adult sample population. Health Psychol. 1993;12(3):171. doi:10.1037/0278-6133.12.3.171
   PubMed Web of Science ®Google Scholar
• Rabin C, Pinto B. Cancer‐related beliefs and health behavior change among breast cancer survivors and their first‐degree relatives. Psycho‐Oncology 2006;15(8):701–712. doi:10.1002/pon.1000
   PubMed Web of Science ®Google Scholar
• McAndrew LM, Musumeci‐Szabó TJ, Mora PA, et al. Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process. Br J Health Psychol. 2008;13(2):195–204. doi:10.1348/135910708X295604
   PubMed Web of Science ®Google Scholar
• Hagger MS, Orbell S. A meta-analytic review of the common-sense model of illness representations. Psychol Health. 2003;18(2):141–184. doi:10.1080/088704403100081321
   Web of Science ®Google Scholar
• Lee‐Jones C, Humphris G, Dixon R, Bebbington Hatcher M. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psycho‐Oncol: J Psychol Soc Behav Dimens Cancer. 1997;6(2):95–105. doi:10.1002/(SICI)1099-1611(199706)6:2<95::AID-PON250>3.0.CO;2-B
   Google Scholar
• Peleg S, Drori E, Banai S, Finkelstein A, Shiloh S. Illness perceptions or recurrence risk perceptions: what comes first? A longitudinal examination among cardiac patients. Eur Health Psychol 2015;17(S):480.
   Google Scholar
• Skinner TC, Hampson SE. Personal models of diabetes in relation to self-care, well-being, and glycemic control: A prospective study in adolescence. Diab Care. 2001;24(5):828–833. doi:10.2337/diacare.24.5.828
   PubMed Web of Science ®Google Scholar
• Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J Std Aids. 2004;15(1):38–44. doi:10.1258/095646204322637245
   PubMed Web of Science ®Google Scholar
• Halm EA, Mora P, Leventhal H. No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest 2006;129(3):573–580.
   PubMed Web of Science ®Google Scholar
• Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psycho‐Oncology 2013;22(5):978–986. doi:10.1002/pon.3114
   PubMed Web of Science ®Google Scholar
• Decruyenaere M, Evers‐Kiebooms G, Welkenhuysen M, Denayer L, Claes E. Cognitive representations of breast cancer, emotional distress and preventive health behaviour: a theoretical perspective. Psycho‐Oncol: J Psychol Soc Behav Dimens Cancer 2000;9(6):528–536. doi:10.1002/1099-1611(200011/12)9:6<528::AID-PON486>3.0.CO;2-#
   Google Scholar
• Freeman‐Gibb LA, Janz NK, Katapodi MC, Zikmund‐Fisher BJ, Northouse L. The relationship between illness representations, risk perception and fear of cancer recurrence in breast cancer survivors. Psycho‐oncology 2017;26(9):1270–1277. doi:10.1002/pon.4143
   PubMed Web of Science ®Google Scholar
• Rees G, Fry A, Cull A. A family history of breast cancer: women's experiences from a theoretical perspective. Soc Sci Med. 2001;52(9):1433–1440. doi:10.1016/S0277-9536(00)00248-3
   PubMed Web of Science ®Google Scholar
• Lemon SC, Zapka JG, Clemow L. Health behavior change among women with recent familial diagnosis of breast cancer. Prev Med. 2004;39(2):253–262. doi:10.1016/j.ypmed.2004.03.039
   PubMed Web of Science ®Google Scholar
• Stewart D, Cheung A, Duff S, et al. Attributions of cause and recurrence in long‐term breast cancer survivors. Psycho‐Oncology 2001;10(2):179–183. doi:10.1002/pon.497
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Coping with cancer in survivorship: follow-up medical care. National Cancer Institute. https://www.cancer.gov/about-cancer/coping/survivorship/follow-up-care. Published 2017. Accessed May 21, 2018.
   Google Scholar
• Nekhlyudov L, Ganz PA, Arora NK, Rowland JH. Going beyond being lost in transition: a decade of progress in cancer survivorship. J Clin Oncol. 2017;35(18):1978. doi:10.1200/JCO.2016.72.1373
   PubMed Web of Science ®Google Scholar
• Grunfeld E, Julian JA, Pond G, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29(36):4755–4762. doi:10.1200/JCO.2011.36.8373
   PubMed Web of Science ®Google Scholar
• Nolte L, Kinnane N, Lai-Kwon J, Gates P, Shilkin P, Jefford M. The impact of survivorship care planning on patients, general practitioners, and hospital-based staff. Cancer Nurs. 2016;39(6):E26–E35. doi:10.1097/NCC.0000000000000329
   PubMed Web of Science ®Google Scholar
• Morse JM. Essentials of Qualitatively-Driven Mixed-Method Designs. 1st ed. New York, NY: Routledge; 2017:3–13.
   Google Scholar
• Parker PA, Banerjee SC, Matasar MJ, et al. Protocol for a cluster randomised trial of a communication skills intervention for physicians to facilitate survivorship transition in patients with lymphoma. BMJ Open. 2016;6(6):e011581. doi:10.1136/bmjopen-2016-011581
   PubMed Web of Science ®Google Scholar
• Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Personal Soc Psychol. 1989;56(2):267. doi:10.1037/0022-3514.56.2.267
   PubMed Web of Science ®Google Scholar
• Litman JA. The COPE inventory: Dimensionality and relationships with approach-and avoidance-motives and positive and negative traits. Personal Indiv Diff. 2006;41(2):273–284. doi:10.1016/j.paid.2005.11.032
   Web of Science ®Google Scholar
• Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–1288. doi:10.1177/1049732305276687
   PubMed Web of Science ®Google Scholar
• Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long‐term (≥ 5 years) cancer survivors—a systematic review of quantitative studies. Psycho‐oncology 2013;22(1):1–11. doi:10.1002/pon.3022
   PubMed Web of Science ®Google Scholar
• Llewellyn CD, Weinman J, McGurk M, Humphris G. Can we predict which head and neck cancer survivors develop fears of recurrence? J Psychosom Res. 2008;65(6):525–532. doi:10.1016/j.jpsychores.2008.03.014
   PubMed Web of Science ®Google Scholar
• Common on Cancer. Draft Revised Standards. A quality program of the American College of Surgeons. 2019.
   Google Scholar
• Cannon AJ, Darrington DL, Reed EC, Loberiza Jr FR. Spirituality, patients’ worry, and follow-up health-care utilization among cancer survivors. J Support Oncol. 2011;9(4):141–148. doi:10.1016/j.suponc.2011.03.001
   PubMedGoogle Scholar
• Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 2011;331(6024):1565–1570. doi:10.1126/science.1203486
   PubMed Web of Science ®Google Scholar
• Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B. Cancer‐related health worries and psychological distress among older adult, long‐term cancer survivors. Psycho‐oncology 2006;15(4):306–320. doi:10.1002/pon.955
   PubMed Web of Science ®Google Scholar